Global Hepatitis C Market 2014-2018

TechNavio Insights

USA – CANADA – UK – CHINA – INDIA

Market Overview: Hepatitis C

About Hepatitis C • Hepatitis C is a liver disease caused by infection due to hepatitis C virus.

• Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected such as the brain and the digestive system.

• Hepatitis C virus is an RNA virus belonging to the family Flaviviridae and genus hepacivirus. It has a positive-sense, single-stranded RNA molecule enveloped by a lipid bilayer.

• Hepatitis C can lead to acute infection or chronic infection.

• Symptoms manifested in the rest include nausea, dark urine, fever, anorexia, gray-colored faces, abdominal pain, and joint pain.

• Currently, there is no vaccine for the prevention of hepatitis C infection; however, various treatment options for hepatitis C infection are available.

• TechNavio's analysts forecast the Global Hepatitis C market to grow at a CAGR of 19.20 percent over the period 2013-2018.

USA – CANADA – UK – CHINA – INDIA

Covered in This Report

• This report covers the present scenario and the growth prospects of the Global Hepatitis C market for the period 2014-2018.

• To calculate the market size, the report considers the revenue generated through sales of various drugs administered to treat chronic hepatitis caused by genotype 1-6 of hepatitis C virus.

• TechNavio's report, the Global Hepatitis C Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.

• The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Hepatitis C market landscape and its growth prospects in the coming years.

• The report includes a discussion of the key vendors operating in this market.

USA – CANADA – UK – CHINA – INDIA

Key Regions

Americas

EMEA

APAC

USA – CANADA – UK – CHINA – INDIA

Key Vendors

Key Vendors• F. Hoffmann-La Roche• Gilead Sciences• Johnson & Johnson• Merck• Vertex Pharmaceuticals

Other Prominent Vendors• Abbvie• Achillion Pharmaceuticals• Bristol-Myers Squibb• Mitsubishi Tanabe Pharma• Novartis

USA – CANADA – UK – CHINA – INDIA

Market Drivers, Challenges and Trends

Guest BloggersDriver• Increase in Injection Drug Users.• For a full, detailed list, view our report.

Challenge• Side-effects of Current Therapy.• For a full, detailed list, view our report.

Trend• Emergence of Interferon-free Therapies.• For a full, detailed list, view our report.

A detailed analysis of each market driver, challenge and trend is

available in our report:

Global Hepatitis C Market 2014-2018

USA – CANADA – UK – CHINA – INDIA

Key Questions

Questions Answered in Our Report• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key

vendors?• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

USA – CANADA – UK – CHINA – INDIA

View Our Report

Global Hepatitis C Market 2014-2018

View Report >>

TechNavio's report, Global Hepatitis C Market 2014-2018, has been prepared based on anin-depth market analysis with inputs from industry experts.

Published on: September 03, 2014 | 101 Pages | SKU: IRTNTR4050

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

More than 2500 Reports in Niche Domains

by 200 Analysts located Globally

In Operation for More than

10 Years with Offices in London, Chicago, Toronto, Beijing &

Bangalore

Cover More than 500 Emerging New

Technologies across 80 Countries in US, EMEA &

APAC Regions

Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps.Option to Customize Report & Access to Analysts on every Report Purchase.

About Us

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501  

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

Mail us at: enquiry@technavio.com

You can visit us at:www.technavio.com

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of

or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION